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9. Does the patient require treatment of thermal injury to greater than 20% of total body surface area?
10. Is the primary reason for admission to the ICU for the treatment of a condition that requires timely nutritional support (Ex. Anorexia nervosa.)?
Body weight < 35 Kg

12.
Height < 140 cm (Demi armspan < 59 cm)
13. Is there a contraindication to treatment with Kabiven G19%?
NB -see next page for contraindications to Kabiven G19% based on TGA licensing indications.
Contraindications to Kabiven G19% based on TGA Licensing Indications.
c1. Known hypersensitivity to egg or soya protein or to any of the ingredients of the study PN (for full ingredients see Product Information, MIMS TGA Document Appendix 1).
c2. Severe hyperlipidaemia (Documented serum total cholesterol >7mmol/L and/or triglycerides >3 mmol/L).
c3.
Severe liver insufficiency (Biopsy proven cirrhosis, or documented portal hypertension with a known past history of either upper GI bleeding attributed to portal hypertension or of hepatic failure leading to encephalopathy / coma.)
c4. Severe blood coagulation disorders (Documented INR > 3.0 not due to coumarin therapy, platelet count <15,000).
c5. Inborn errors of amino acid metabolism (Ex. PKU etc)
c6. Severe renal insufficiency without access to haemofiltration or dialysis.
c7. Acute shock as defined by arterial systolic blood pressure ≤ 90mmHg or mean arterial pressure ≤ 70mmHg despite adequate fluid resuscitation (i.e. following rapid infusion of ≥ 500mL crystalloid or 200mL colloid solution and /or PAOP ≥ 12mmHg, CVP ≥ 8mmHg) or increasing need for noradrenaline / adrenaline / dopamine to maintain blood pressure where the infusion rate has increased by more that 50% over the previous hour to greater than 0.6mg/hour (10 mcg/min) norad / adrenaline or 30mg dopamine.
Patients are not excluded if their initial shock responds to fluid therapy or if the catecholamine infusion rate has not increased by more than 50% over the previous one hour period or if the current infusion rate is less than 0.6mg norad / adrenaline per hour .
c8. Hyperglycaemia (blood sugar > 10 mmol/L) that currently requires the administration of more than 6 units of insulin/hour at the time of enrolment. • Commence Kabiven G19% at 60ml/hr (or goal rate, whichever is lower).
• Consider trace element, mineral and vitamin needs as clinically appropriate.
Feeding Day 2 (second 24 hours of PN)
• Increase Kabiven G19% to 80ml/hr (or goal rate, whichever is lower).
Feeding Day 3 (next 24 hours)
• Increase Kabiven G19% to goal rate, as appropriate.
• Consider trace element, mineral and vitamin needs, as clinically appropriate.
• Recommend trialing enteral/oral nutrition, if clinically appropriate.
• Once the patient tolerates ≥ 475 kcal/day EN, complete remainder of 24 hour Kabiven infusion and do not hang another bag.
• If patient tolerates any oral caloric intake from food, complete remainder of 24 hour Kabiven infusion and do not hang another bag.
Feeding Day 4 (next 24 hours) plus all additional days after Day 4
• May switch to parenteral nutrition solution tailored to patient's specific clinical needs. Goals not to exceed 25-35 kcal/kg and 1.0-1.5 g protein/kg.
• Consider long term needs regarding trace element, mineral and vitamins as clinically appropriate.
INSULIN / GLUCOSE PROTOCOL: Early PN Patients
If glucose levels exceed 10 mmol/L an insulin infusion should be commenced and titrated to achieve peak serum glucose levels of < 10 mmol/L. Frequent monitoring of the patient's blood glucose should be initiated as per your ICU's usual practice for patients receiving an insulin infusion.
If insulin infusion is required at ≥ 6 units/hr to maintain glucose target:
• Reduce Kabiven G19% to 40ml/hr for 24 hours.
• At the end of 24 hours, if insulin needs are reduced below 6 units/hr, increase Kabiven G19% to 80mls (or original goal rate, whichever is lower) for 24 hours.
• At the end of this second 24 hour period, if insulin needs remain below 6 units/hr, increase Kabiven G19% to goal rate.
• If insulin requirements exceed 6 units/hr at any time during the above process, reduce PN to previously tolerated rate, or 40 mls/hr (whichever is higher), for 24 hours. Begin increasing rate every 24 hours as above, if tolerated.
eTable 2 continued: PN Protocols
Study PN Protocol B: MALNOURISHED Early PN PATIENTS (Ex. BMI ≤ 17): Feeding Day 1 (first 24 h of PN)
• Commence Kabiven G19% at 40ml/hr (or goal rate, whichever lower).
• Strongly recommend administering 100mg thiamine, commencing at least 30 minutes prior to initiation of Kabiven G19% infusion, as clinically indicated as per product licensing indications.
• Recommend daily administration of other vitamins, minerals and trace elements, as clinically appropriate.
Feeding Day 2 (second 24 hours of PN)
• Increase Kabiven G19% to 60ml/hr (or goal rate, whichever is lower).
• Recommend daily administration of vitamins, minerals and trace elements, as clinically appropriate.
Feeding Day 3 (next 24 hours)
Feeding Day 4 (next 24 hours) plus all additional days after Day 4
• Strongly recommend addressing long term needs regarding trace elements, minerals and vitamins as clinically appropriate.
INSULIN / GLUCOSE PROTOCOL: Early PN Patients
• If insulin requirements exceed 6 units/hr at any time during the above process, reduce PN to previously tolerated rate, or 40 mls/hr (whichever is higher), for 24 hours. Begin increasing rate every 24 hours as above, if tolerated. Other, not listed below <value="1.2">
• Any other problem, not listed below.
Infection, mild <value="1.3">
• Ex. mild skin, line or surgical wound infection. Local redness, heat and swelling but no systemic signs.
Operation, minor <value="1.3">
• Any surgical procedure that does not require general anaesthesia or respiratory support.
Operation, major <value="1. Trauma, single long-bone fracture <value="1.45">
• Trauma with a fracture to a long bone (femur, humerus, tibia, fibula, radius and ulna).
Trauma, multiple fractures <value="1.5">
• Trauma with multiple fractures to any bones, including at least one long bone.
Trauma, blunt with or without fractures <value="1.6">
• Blunt trauma, such as a motor vehicle crash and fall from height. Includes Penetrating trauma.
Infection, severe <value="1.65">
• Any infection, or suspected infection, that expresses itself systemically as sepsis.
Burns, less than or equal to 20% TBSA <value="1.7">
• Chemical or thermal burns to less than 20% of total body surface area.
Malnourished (high risk of refeeding syndrome) <value="0.85"> 
